期刊
NATURE REVIEWS CANCER
卷 14, 期 9, 页码 611-622出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc3793
关键词
-
类别
资金
- Samuel Waxman Cancer Research Foundation Tumour Dormancy Program
- US National Institutes of Health/National Cancer Institute [CA109182, CA163131]
- DoD-BCRP Grant [BC112380]
- CDMRP [BC112380, 545499] Funding Source: Federal RePORTER
Metastases arise from residual disseminated tumour cells (DTCs). This can happen years after primary tumour treatment because residual tumour cells can enter dormancy and evade therapies. As the biology of minimal residual disease seems to diverge from that of proliferative lesions, understanding the underpinnings of this new cancer biology is key to prevent metastasis. Analysis of approximately 7 years of literature reveals a growing focus on tumour and normal stem cell quiescence, extracellular and stromal microenvironments, autophagy and epigenetics as mechanisms that dictate tumour cell dormancy. In this Review, we attempt to integrate this information and highlight both the weaknesses and the strengths in the field to provide a framework to understand and target this crucial step in cancer progression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据